Literature DB >> 12568781

Optimization of protein therapeutics by directed evolution.

Alain P Vasserot1, Craig D Dickinson, Ying Tang, William D Huse, Keith S Manchester, Jeffry D Watkins.   

Abstract

Directed evolution is a broadly applicable technology platform that is ideally suited to address the need for protein optimization and to fully exploit the therapeutic potential of biologics. The approach takes advantage of the remarkable structural and functional plasticity of proteins and permits the rapid remodeling of biologics into new entities with improved functions. The ability to ameliorate virtually any characteristic of a protein can translate into significant clinical benefits, including decreased immunogenicity, higher potency, greater efficacy and improved safety profile, and can considerably increase the probability of successfully developing and commercializing biotherapeutics.

Mesh:

Year:  2003        PMID: 12568781     DOI: 10.1016/s1359-6446(02)02590-4

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  6 in total

1.  Somatic hypermutation maintains antibody thermodynamic stability during affinity maturation.

Authors:  Feng Wang; Shiladitya Sen; Yong Zhang; Insha Ahmad; Xueyong Zhu; Ian A Wilson; Vaughn V Smider; Thomas J Magliery; Peter G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-25       Impact factor: 11.205

2.  Directed evolution of bacteriorhodopsin for applications in bioelectronics.

Authors:  Nicole L Wagner; Jordan A Greco; Matthew J Ranaghan; Robert R Birge
Journal:  J R Soc Interface       Date:  2013-05-15       Impact factor: 4.118

3.  Selection Finder (SelFi): A computational metabolic engineering tool to enable directed evolution of enzymes.

Authors:  Neda Hassanpour; Ehsan Ullah; Mona Yousofshahi; Nikhil U Nair; Soha Hassoun
Journal:  Metab Eng Commun       Date:  2017-03-01

4.  Data driven flexible backbone protein design.

Authors:  Mark G F Sun; Philip M Kim
Journal:  PLoS Comput Biol       Date:  2017-08-24       Impact factor: 4.475

5.  A population-based experimental model for protein evolution: effects of mutation rate and selection stringency on evolutionary outcomes.

Authors:  Aaron M Leconte; Bryan C Dickinson; David D Yang; Irene A Chen; Benjamin Allen; David R Liu
Journal:  Biochemistry       Date:  2013-02-14       Impact factor: 3.162

6.  Generation and characterization of ixekizumab, a humanized monoclonal antibody that neutralizes interleukin-17A.

Authors:  Ling Liu; Jirong Lu; Barrett W Allan; Ying Tang; Jonathan Tetreault; Chi-Kin Chow; Barbra Barmettler; James Nelson; Holly Bina; Lihua Huang; Victor J Wroblewski; Kristine Kikly
Journal:  J Inflamm Res       Date:  2016-04-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.